BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Revenue

In the year 2025, BridgeBio Pharma had annual revenue of $502.08M with 126.26% growth. BridgeBio Pharma had revenue of $154.18M in the quarter ending December 31, 2025, with 2,521.18% growth.

• Revenue (ttm): $502.08M
• Revenue Growth: +126.26%
• P/S Ratio: 26.38
• Revenue / Employee: $598,422
• Employees: 839
• Market Cap: 13.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	502.08M	280.17M	126.26%
Dec 31, 2024	221.90M	212.60M	2,285.27%
Dec 31, 2023	9.30M	-68.35M	-88.02%
Dec 31, 2022	77.65M	7.93M	11.38%
Dec 31, 2021	69.72M	61.47M	745.14%
Dec 31, 2020	8.25M	-32.31M	-79.66%
Dec 31, 2019	40.56M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-